香港六合彩

XClose

香港六合彩 Faculty of Medical Sciences

Home
Menu

香港六合彩 announces new collaboration with Cerveau Technologies

7 May 2020

香港六合彩 has announced a new collaboration with Cerveau Technologies, which will enable 香港六合彩 to manufacture and distribute the imaging agent called [18F]MK-6240.

香港六合彩 Medical Sciences collaboration with Cerveau Technologies

The imaging agent [18F]MK-6240 will be used by 香港六合彩 in clinical studies to assess the status and progression of neurofibrillary tangles (NFTs) in the brain. These NFTs are a hallmark of several neurodegenerative diseases, including Alzheimer鈥檚 Disease. 香港六合彩 is the first site able to distribute GMP-produced [18F]MK-6240 in the United Kingdom.

Professor Erik Arstad, the Director of the 香港六合彩 Centre for Radiopharmaceutical Chemistry, said 鈥淭he team at the 香港六合彩 Centre for Radiopharmaceutical Chemistry is delighted to provide [18F]MK-6240 to our clinical collaborators at the 香港六合彩 Dementia Research Centre and the wider biomedical research community in the UK. As the best-in-class imaging biomarker for neurofibrillary tangles (NFTs) in the brain, [18F]MK-6240 will facilitate UK led research into the understanding and treatment of Alzheimer鈥檚 Disease.鈥